What Intuitive Surgical's Quarter ended Sep 30, 2026 10-Q says: 2 signals
Intuitive Surgical filed its latest 10-Q with the SEC on Oct 21, 2026. It discusses acquisition completed and inflation impact.
Public (ISRG)Medical Equipment Manufacturing10,000+ employeesintuitive.comLinkedIn
Get Intuitive Surgical's live signals in Claude or ChatGPT, or by API
What changed at Intuitive Surgical this week? Use Autobound signals for intuitive.com.- Filed
- Oct 21, 2026
- Period
- Quarter ended Sep 30, 2026
- Filings
- 3
- Signals
- 8
Source: Autobound Signal API · 64 signals tracked for Intuitive Surgical · updated
10-Q · latest 7
What Intuitive Surgical's 10-Q filings say
- SEC EDGAR
10-Q · Quarter ended Sep 30, 2026
Filed · 2 signals
Intuitive Surgical finalized the acquisition of its da Vinci and Ion distribution businesses in Italy, Spain, and Portugal as part of a transition to a direct sales model.
Tariffs and trade measures added $23.4M in Q3 2026 and $72.4M YTD to revenue costs
Intuitive Surgical recognized $23.4 million for the three months and $72.4 million for the nine months ended September 30, 2026 in total cost of revenue from tariffs and other trade measures.
$23.4M
tariffs and other trade measures recognized in total cost of revenue in Q3 2026
- SEC EDGAR
10-Q · Quarter ended Jun 30, 2026
Filed · 3 signals
Tariffs and trade measures recognized in cost of revenue reached $20.8M for Q2 2026
During the three and six months ended June 30, 2026, tariffs and trade measures recognized in total cost of revenue were $20.8 million and $48.8 million, partially offset by $35.9 million in refunds.
$20.8M
tariffs and other trade measures recognized in total cost of revenue for the three months ended June 30, 2026
The company completed the acquisition of its distribution businesses in Italy, Spain, and Portugal, transitioning to a direct sales model in those markets.
- SEC EDGAR
10-Q · Quarter ended Mar 31, 2026
Filed · 3 signals
Intuitive recently completed the acquisition of da Vinci and Ion distribution businesses in Italy, Spain, and Portugal to transition from a distributor model to direct sales.
Intuitive Surgical Secures FDA Clearance for Force Feedback Instruments on da Vinci 5 in March 2026
In March 2026, the company obtained FDA clearance for updates to its force feedback instruments used with the da Vinci 5 surgical system, clearing five instruments for up to 15 uses and one for up to 10 uses.
force feedback instruments
Intuitive Surgical recognized approximately $28 million in tariffs and trade measures within total cost of revenue during the three months ended March 31, 2026.
$28M
tariffs and other trade measures recognized in total cost of revenue
Showing 7 of 8 filing signals. The Signal API returns all of them.
Get them with one API callEarnings calls
Intuitive Surgical earnings headlines
From earnings call transcripts (Signal API type earnings-transcripts).
| Call date | What the company said |
|---|---|
| Revenue grew 22% to over $3B, operating margin 42%Intuitive reported Q3 revenue exceeding $3 billion, up 22% year-over-year, driven by 84% recurring revenue. Non-GAAP operating margin reached 42% (or 41% excluding a $28 million tariff refund), with non-GAAP EPS growing 25% to $3.00. Strong revenue growth signals robust financial capacity for expanded vendor engagements. | |
| Regulatory settlement incurs $450M charge over third-party remanufacturingIntuitive Surgical reached an agreement resolving class action litigation regarding third-party instrument remanufacturing and servicing, recording a $450M litigation settlement in GAAP results. The settlement remains subject to court approval expected next year, depressing GAAP net income to $523 million from $704 million year-over-year. | |
| Extended use instrument pricing initiative lowering customer procedure costsBeginning H1 2027, Intuitive is rolling out an expanded extended use program to extend the useful life of core EndoWrist instruments and introduce volume-based pricing. The initiative aims to capture high-volume benign procedures across ambulatory and international settings by lowering customer cost barriers, expecting to impact I&A procedure revenue by 3% to 5%. | |
| China policy changes trigger mandatory I&A price cutsImplementation of provincial charge code policies in China will enforce significant price reductions on Instruments & Accessories (I&A) beginning in November. Combined with the company's extended use program, this regulatory mandate will cause an estimated 3% to 5% reduction in da Vinci I&A revenue per procedure on a mix-constant basis. | |
| Modular robotic competitors target ambulatory surgery center accountsCompetitors Stryker and CMR Surgical are introducing modular robotic surgical offerings targeted directly at ASC environments where Intuitive currently sees less than 10% penetration. Intuitive is actively defending this segment using its lower-cost XiR cart-based platform and specialized volume-based instrument pricing. | |
| Input costs rise across semiconductor memory and global freightThe company forecasts sustained cost pressure in key component categories including semiconductor memory and shipping freight. Management updated non-GAAP gross margin guidance to 68.7%-69.3%, which also includes an estimated 90 basis point net impact from tariffs and related refunds. |
Signal API · MCP
Track Intuitive Surgical with the Signal API
One POST /v1/companies/enrich call with intuitive.com returns Intuitive Surgical 10-Q signals (sec-10q), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"intuitive.com","signal_types":["sec-10q"],"limit":20}'Bulk data
Need this signal for 10,000+ companies?
Get a free sample file or a bulk feed (API, GCS push, flat file). The sample is real 10-Q Filings records, as a CSV.
Same industry
10-Q at related companies
Questions about Intuitive Surgical 10-Q
When did Intuitive Surgical file its latest 10-Q?
What did Intuitive Surgical disclose in its latest 10-Q?
What did Intuitive Surgical say on its recent earnings calls?
Where can I read Intuitive Surgical's 10-Q filing?
Page updated , the date of the newest row on this page.
Source. Quarterly reports (Form 10-Q) filed with the SEC. Every card links to the filing on EDGAR.
Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.
Data as of .